Members |
targetComponentId |
Chlormethiazole edisylate 8mg/mL infusion |
Product containing clomethiazole (medicinal product) |
Chlorofluorocarbon |
Chlorofluorocarbon |
Chlorofluorocarbon |
Freon |
Chloroform |
Chloroform |
klorokinfosfat 80 mg/5 ml, sirap |
Product containing precisely chloroquine phosphate 16 milligram/1 milliliter conventional release oral solution (clinical drug) |
klorokinsulfat 68 mg/5 ml, sirap |
Product containing precisely chloroquine sulfate 13.6 milligram/1 milliliter conventional release oral solution (clinical drug) |
klorfeniraminmaleat 10 mg/ml, injektionsvätska |
Chlorphenamine maleate 10 mg/mL solution for injection |
klorfeniraminmaleat 2 mg/5 ml, sockerfri sirap |
Chlorphenamine maleate 400 microgram/mL oral solution |
klorfeniraminmaleat 2 mg/5 ml, sirap |
Chlorphenamine maleate 400 microgram/mL oral solution |
klorpromazinhydroklorid 100 mg/5 ml, sockerfri oral lösning |
Chlorpromazine hydrochloride 20 mg/mL oral solution |
klorpromazinhydroklorid 100 mg/5 ml, sockerfri suspension |
Chlorpromazine hydrochloride (as chlorpromazine embonate) 20 mg/mL oral suspension |
Chlorpromazine hydrochloride 100mg/5mL syrup |
Chlorpromazine hydrochloride 20 mg/mL oral solution |
Chlorpromazine hydrochloride 25mg injection solution 1mL vial |
Product containing precisely chlorpromazine hydrochloride 25 milligram/1 milliliter conventional release solution for injection (clinical drug) |
klorpromazinhydroklorid 25 mg/ml, injektionsvätska |
Product containing precisely chlorpromazine hydrochloride 25 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Chlorpromazine hydrochloride 25mg/1mL injection |
Product containing precisely chlorpromazine hydrochloride 25 milligram/1 milliliter conventional release solution for injection (clinical drug) |
klorpromazinhydroklorid 25 mg/5 ml, sockerfri oral lösning |
Chlorpromazine hydrochloride 5 mg/mL oral solution |
klorpromazinhydroklorid 25 mg/5 ml, sirap |
Chlorpromazine hydrochloride 5 mg/mL oral solution |
Chlorpromazine hydrochloride 25mg/mL injection |
Product containing precisely chlorpromazine hydrochloride 25 milligram/1 milliliter conventional release solution for injection (clinical drug) |
klorpromazinhydroklorid 25 mg/ml, injektionsvätska, lösning, ampull 2 ml |
Product containing precisely chlorpromazine hydrochloride 25 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Chlorpromazine hydrochloride 50mg/2mL injection |
Product containing precisely chlorpromazine hydrochloride 25 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Choanotaeniaart |
Choanotaenia |
Choking |
Choking sensation (finding) |
Choking |
Choking |
Choking: [symptom] or [sensation] |
Choking sensation (finding) |
kateter för endoskopisk retrograd kolangio-pankreatografi, flergångs |
Cholangiopancreatography catheter (physical object) |
kateter till endoskopisk, retrograd kolangiopankreatografi, engångs |
Cholangiopancreatography catheter (physical object) |
Cholecalciferol or ergocalciferol |
Product containing ergocalciferol (medicinal product) |
Cholecalciferol or ergocalciferol |
Product containing colecalciferol (medicinal product) |
Cholecystectomy: [total NEC] or [NEC] |
Cholecystectomy |
Cholecystoenterostomy |
Cholecystojejunostomy |
Cholecystojejunostomy (& Roux en Y) |
Roux-en-Y cholecystojejunostomy |
Cholecystojejunostomy (& Roux en Y) |
Cholecystojejunostomy |
mätning av kolecystokinin |
Measurement of cholecystokinin in serum |
Choledochoduodenostomy |
Duodenocholedochotomy |
Choledochoduodenostomy |
Choledochoduodenostomy |
Choledocholithotomy |
Choledocholithotomy (procedure) |
Choledocholithotomy |
Choledochostomy with removal of calculus |
Choledocholithotomy |
Bile duct stone removal (procedure) |
Choledocholithotomy: [open NEC] or [NEC] |
Bile duct stone removal (procedure) |
Cholelithiasis |
Calculus of cystic duct |
Cholelithiasis |
Biliary calculus |
Cholelithiasis |
Calculus of bile duct |
Cholelithiasis |
Gallstone |
Cholera contact |
Exposure to Vibrio cholerae (event) |
exponering för kolera |
Exposure to Vibrio cholerae (event) |
vaccin mot kolera |
Vibrio cholerae antigen-containing vaccine product |
koleravaccin |
Vibrio cholerae antigen-containing vaccine product |
Cholesteatoma &/or aural polyp |
Cholesteatoma and aural polyp |
Cholesteatoma &/or aural polyp |
Cholesteatoma of middle ear |
Cholesteatoma of middle ear AND/OR mastoid |
Cholesteatoma of middle ear and mastoid (disorder) |
kolesteatom i mellanöra och/eller processus mastoideus |
Cholesteatoma of middle ear and mastoid (disorder) |
Cholesterol embolization syndrome |
Cholesterol embolus syndrome |
Cholesterol embolization syndrome |
Ischemic toe |
kolesterolrelaterad artrit och periartrit |
Secondary osteoarthritis (disorder) |
kolestyramin 4 g/ dospåse, sockerfritt pulver |
Colestyramine 4 g powder for oral suspension sachet |
Cholestyramine sug free powder 4g/sachet |
Colestyramine 4 g powder for oral suspension sachet |
Cholestyramine sug free powder 4g/sachet |
Colestyramine 4 g powder for oral suspension sachet |
Cholestyramine sugar free powder |
Colestyramine 4 g powder for oral suspension sachet |
kolinerg anafylaktisk reaktion |
Non-allergic anaphylaxis caused by organic phosphorous compound (disorder) |
kolinerg anafylaktisk reaktion |
Non-allergic anaphylaxis caused by parasympathomimetic agent |
Cholinesterase genotype |
Butyrylcholinesterase genotype determination (procedure) |
Cholinesterase genotype |
Butyrylcholinesterase genotype determination (procedure) |
Cholinesterase genotype |
Butyrylcholinesterase genotype determination (procedure) |
genotypbestämning av kolinesteras |
Butyrylcholinesterase genotype determination (procedure) |
kolinesterashämmare |
Acetylcholinesterase inhibitor (disposition) |
mätning av kolinesteras |
Butyrylcholinesterase measurement (procedure) |
Cholinesterase phenotype |
Butyrylcholinesterase phenotype determination (procedure) |
Cholinesterase phenotype |
Butyrylcholinesterase phenotype determination (procedure) |
bestämning av kolinesterasfenotyp |
Butyrylcholinesterase phenotype determination (procedure) |
kolinesterasreaktivator |
Acetylcholinesterase reactivator |
biverkning av kolinesterasreaktivator |
Acetylcholinesterase reactivator adverse reaction (disorder) |
screeningtest avseende kolinesteras |
Butyrylcholinesterase screening test |
kondrokalcinos orsakad av dikalciumfosfatkristaller, i underarm |
Chondrocalcinosis due to dicalcium phosphate crystals |
kondrokalcinos orsakad av dikalciumfosfatkristaller, i underben |
Chondrocalcinosis due to dicalcium phosphate crystals |
kondrokalcinos orsakad av dikalciumfosfatkristaller, i överarm |
Chondrocalcinosis due to dicalcium phosphate crystals, of the shoulder region |
Chondrocalcinosis due to pyrophosphate crystals of: [lower leg] or [knee] |
Chondrocalcinosis due to pyrophosphate crystals of the knee |
kondrokalcinos orsakad av pyrofosfatkristaller, i underarm |
Chondrocalcinosis due to pyrophosphate crystals (disorder) |
kondrokalcinos orsakad av pyrofosfatkristaller, i underbenet |
Chondrocalcinosis due to pyrophosphate crystals of the knee |
kondrokalcinos orsakad av pyrofosfatkristaller, i överarm |
Chondrocalcinosis due to pyrophosphate crystals, of the shoulder region |
Chondrodysplasia punctata |
Epiphyseal dysplasia |
Chondrodysplasia punctata |
Chondrodysplasia punctata |
Chondrodysplasia punctata |
Chondrodysplasia punctata, X-linked dominant type (disorder) |
Chondrodysplasia punctata |
Chondrodysplasia punctata congenita |
Chondrodysplasia punctata |
Chondrodysplasia punctata, Conradi-Hünermann type (disorder) |
Chondrodysplasia punctata, Conradi-Hünermann type |
Chondrodysplasia punctata, Conradi-Hünermann type (disorder) |
Chondrodysplasia punctata, Conradi-Hünermann type |
Chondrodysplasia punctata, X-linked dominant type (disorder) |
kondrodysplasi, specificerat på annat sätt |
Chondrodysplasia (disorder) |
kondrodystrofisk malaci |
Degenerative disorder |
kondrodystrofisk malaci |
Disorganized development of cartilaginous and fibrous components of the skeleton |
Chorea |
Abnormal involuntary movement |
Chorea |
Chorea |
korioallantoisplacenta |
Anomaly of placenta (disorder) |
Chorioamnionitis |
Chorioamnionitis |
Chorioamnionitis |
Infection of amniotic cavity |
koriogonadotropin alfa 250 mikrogram, injektionsvätska, lösning, förfylld spruta 0,5 ml |
Product containing precisely choriogonadotropin alfa 500 microgram/1 milliliter conventional release solution for injection (clinical drug) |
mätning av koriogonadotropin |
Human chorionic gonadotropin measurement |
Chorionic gonadotropin, beta-subunit measurement |
Chorionic gonadotropin, beta-subunit measurement, spinal fluid (procedure) |
Chorionic gonadotropin, beta-subunit measurement |
Chorionic gonadotropin, beta-subunit measurement (procedure) |
särskilda tester av hjärt-kärlsystemet |
Sampling of chorionic villus |
Chorioptes species |
Chorioptes |
korioretinalt ärr på bakre ögonpol i båda ögonen |
Bilateral scar of posterior pole of retinas |